- Report
- April 2020
- 182 Pages
Global
From €3688EUR$4,000USD£3,127GBP
- Report
- January 2020
- 30 Pages
China
From €2028EUR$2,200USD£1,720GBP
- Report
- January 2020
- 156 Pages
Japan
From €4149EUR$4,500USD£3,518GBP
- Drug Pipelines
- January 2020
- 1500 Pages
Global
From €2766EUR$3,000USD£2,345GBP
- Report
- March 2019
- 80 Pages
Global
From €3227EUR$3,500USD£2,736GBP
- Clinical Trials
- September 2018
- 700 Pages
Global
From €2766EUR$3,000USD£2,345GBP
- Drug Pipelines
- January 2018
- 16 Pages
Global
From €9220EUR$10,000USD£7,818GBP
From €3227EUR$3,500USD£2,736GBP
- Report
- October 2026
Global
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
North America
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
Europe
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
North America
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
Europe
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
Middle East
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
Asia Pacific
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
United States
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
United Kingdom
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
China
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
Europe
From €3679EUR$3,990USD£3,119GBP
- Report
- October 2026
United States
From €3679EUR$3,990USD£3,119GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more